Skip to Content

Join the 'Chronic Obstructive Pulmonary Disease, Maintenance' group to help and get support from people like you.

Chronic Obstructive Pulmonary Disease, Maintenance News

Related terms: COPD, Maintenance

Health Tip: Understanding COPD

Posted 13 days ago by Drugs.com

-- Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death in the United States, affecting some 16 million Americans and potentially millions more who don't know they have it. According to the National Heart, Blood, and Lung Institute, COPD can make it difficult for people to breathe and harm their quality of life. In COPD, less air flows in and out of the lung's airways due to one or more of these factors: The airways lose their elastic quality. The walls between some of the air sacs are destroyed. The walls of the airways become thick and inflamed. The airways make more mucus than usual and become clogged. Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Alpha-1 Proteinase Inhibitor Deficiency, Respiratory Tract Disease

Rheumatoid Arthritis Linked to Risk of COPD

Posted 31 Oct 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – People with rheumatoid arthritis appear to have a higher risk of the lung condition chronic obstructive pulmonary disease (COPD), researchers report. The study found that people with rheumatoid arthritis were 47 percent more likely to be hospitalized for COPD than those in the general population. Rheumatoid arthritis is an autoimmune disease. That means the body's immune system mistakenly attacks healthy tissue instead of foreign invaders such as bacteria. This causes inflammation, which causes symptoms such as red, swollen and painful joints, according to the Arthritis Foundation. COPD includes diseases such as emphysema and chronic bronchitis. Symptoms include shortness of breath, frequent coughing, a feeling of tightness in the chest and wheezing, the COPD Foundation says. Smoking and secondhand smoke are among the most significant risk factors for COPD. ... Read more

Related support groups: Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Ribavirin, Qvar, Budesonide, Flovent, Entocort, Tobramycin, Chronic Obstructive Pulmonary Disease, Acute, Entocort EC, Mometasone, Beclomethasone, Uceris, Alvesco, Pulmicort Flexhaler, Pulmicort Turbuhaler, Asmanex Twisthaler, Copegus

Switch From Smoking to Vaping Could Save Over 6 Million U.S. Lives

Posted 3 Oct 2017 by Drugs.com

MONDAY, Oct. 2, 2017 – Millions of cigarette smokers could live substantially longer if electronic cigarettes are embraced as a replacement for tobacco during the next decade, a new study contends. As many as 6.6 million cigarette smokers could live a combined 86.7 million more years under policies that encourage them to swap their smokes for e-cigarettes, according to "optimistic" projections from cancer researchers at Georgetown University in Washington, D.C. Even a worst-case scenario involving e-cigarettes would still save lives, the researchers said. Under a "pessimistic" projection, 1.6 million former cigarette smokers would have a combined 20.8 million more years of additional life, the research team found. These numbers show that adopting e-cigarettes as an alternative to smoking could prove the easiest way to cause tobacco use to dwindle in the United States, said lead ... Read more

Related support groups: Cough, Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Small Cell Lung Cancer, Chronic Obstructive Pulmonary Disease, Acute, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Respiratory Tract Disease, Nicorelief, Nicorette DS, Nicotrol NS, ProStep

Respiratory Disease Death Rates Have Soared

Posted 29 Sep 2017 by Drugs.com

FRIDAY, Sept. 29, 2017 – The number of Americans who die from chronic respiratory diseases has skyrocketed over the past 35 years, led in large part by deaths from COPD, a new report indicates. From 1980 through 2014, more than 4.6 million Americans died from a range of chronic respiratory illnesses, the researchers reported. While the risk was pegged at 41 deaths for every 100,000 people back in 1980, it rose to nearly 53 out of every 100,000 by 2014, representing a nearly 31 percent spike over 35 years. And the dismal news continued in the new report. Eighty-five percent of the deaths – 3.9 million people – were from chronic obstructive pulmonary disease (COPD), which moved up in that period of time to become the third leading cause of death, ahead of stroke, in the United States. Other chronic respiratory illnesses that saw dramatic increases included: particle-inhalation ... Read more

Related support groups: Cough, Chronic Obstructive Pulmonary Disease, Pneumonia, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Ribavirin, Qvar, Budesonide, Flovent, Entocort, Tobramycin, Chronic Obstructive Pulmonary Disease, Acute, Entocort EC, Mometasone, Bronchiectasis, Beclomethasone, Uceris, Alvesco, Pulmicort Flexhaler, Pulmicort Turbuhaler

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD

Posted 19 Sep 2017 by Drugs.com

London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the brand name Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, who are on a fixed-dose combination of fluticasone furoate and vilanterol for airflow obstruction and reducing exacerbations in whom additional treatment of airflow obstruction is desired or for patients who are already receiving umeclidinium and a fixed-dose combination of fluticasone furoate and vilanterol. Trelegy Ellipta is not indicated for relief of acute bronchospasm or the treatment of asthma. Trelegy E ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Breo Ellipta, Chronic Obstructive Pulmonary Disease, Acute, Anoro Ellipta, Arnuity Ellipta, Umeclidinium, Umeclidinium/vilanterol, Incruse Ellipta, Trelegy Ellipta, Fluticasone/umeclidinium/vilanterol, Fluticasone/vilanterol

Statins May Help People With COPD Live Longer

Posted 8 Sep 2017 by Drugs.com

FRIDAY, Sept. 8, 2017 – Drugs known as statins may have benefits beyond lowering "bad" LDL cholesterol levels. A new study suggests people with chronic lung disease who take these drugs may extend their survival. The study from Canada included nearly 40,000 people with chronic obstructive pulmonary disease (COPD). One in five patients was taking a statin, and those individuals had a 21 percent lower risk of dying from any cause, and a 45 percent reduced risk of dying from lung-related issues, the researchers found. This study comes on the heels of a separate large-scale investigation that found no link between statin use and the number of COPD exacerbations people experienced. "While evidence from a recently completed [randomized controlled trial] suggested that statin use is of little benefit to COPD patients, this population-based analysis showed that statin use reduced all-cause ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, High Cholesterol, Lipitor, Simvastatin, Atorvastatin, Crestor, Pravastatin, Chronic Obstructive Pulmonary Disease, Maintenance, Zocor, Lovastatin, Rosuvastatin, Chronic Obstructive Pulmonary Disease, Acute, Red Yeast Rice, Pravachol, Livalo, Alpha-1 Proteinase Inhibitor Deficiency, Lescol XL, Lescol, Mevacor, Altoprev

Long-Acting Inhaler May Help in Early Stage COPD, Too

Posted 6 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 6, 2017 – The inhaler medication Spiriva (tiotropium bromide) may help slow the progression of COPD if given in the early stages of the disease, a new study suggests. Researchers found that the drug helped patients preserve more lung function over two years. It also cut down on symptom flare-ups and boosted patients' quality of life, on average. All of the study patients were in the early stages of chronic obstructive pulmonary disease, or COPD – a group of serious lung conditions that include emphysema and chronic bronchitis. Experts said the study, funded by Spiriva maker Boehringer Ingelheim, could help change the way early COPD is managed. Until now, nothing has been shown to slow the progression of early COPD – other than smoking cessation, said Dr. Louis DePalo, a lung disease specialist who wasn't involved in the study. "Quitting smoking is the one thing ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Spiriva HandiHaler, Tiotropium, Stiolto Respimat, Spiriva Respimat, Alpha-1 Proteinase Inhibitor Deficiency, Olodaterol/tiotropium

Smoking Linked to Frailty in Seniors

Posted 29 Aug 2017 by Drugs.com

TUESDAY, Aug. 29, 2017 – Seniors who smoke may be more likely to become frail, a new British study suggests. Researchers tracked more than 2,500 people 60 and older in England and found that current smoking boosted that risk by about 60 percent. The scientists determined that the participants were frail if they had at least three of five conditions: unintentional weight loss, self-reported exhaustion, weakness, slow walking speed, and low physical activity. Frail people are at higher risk of problems such as falls, broken bones and hospitalization. Researchers have also linked frailty to poor quality of life and dementia. Interestingly, the researchers found that former smokers didn't face a higher risk of frailty, and it didn't matter if they'd quit within the past 10 years or earlier. In fact, their risks of frailty were about the same as those who had never smoked. The research team ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Nicotine, Nicorette, Chronic Obstructive Pulmonary Disease, Acute, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, Nicorelief, Nicorette DS, Nicotrol NS, ProStep, Nicotrol TD

FDA: Serious Problems at Florida Stem Cell Clinic

Posted 29 Aug 2017 by Drugs.com

A Florida stem cell clinic has been cited by the U.S. Food and Drug Administration for what the agency describes as serious problems that could pose health risks to patients. The agency said Monday that it has cited US Stem Cell Clinic, of Sunrise, for marketing stem cell products without FDA approval and for "significant deviations from current good manufacturing practice requirements," including some that could affect the "sterility of their products, putting patients at risk." "Stem cell clinics that mislead vulnerable patients into believing they are being given safe, effective treatments that are in full compliance with the law are dangerously exploiting consumers and putting their health at risk," FDA Commissioner Dr. Scott Gottlieb said in a news release. The FDA said it recently inspected US Stem Cell Clinic and found that it was processing fat tissue into stem cells derived ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Heart Disease, Parkinson's Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Amyotrophic Lateral Sclerosis, Chronic Obstructive Pulmonary Disease, Acute, Diagnosis and Investigation, Parkinsonism, Parkinsonian Tremor

Nearly 4 Million Worldwide Die Each Year From Asthma, COPD

Posted 17 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 16, 2017 – Two major chronic lung diseases – asthma and COPD – kill nearly 4 million people worldwide annually, a new report finds. The study calculates that 3.2 million people died in 2015 from COPD (chronic obstructive pulmonary disease) – a group of lung conditions that includes emphysema and chronic bronchitis, often tied to smoking. Asthma caused another 400,000 deaths, the report found. While asthma is more common, COPD is much more deadly. And while both conditions can be treated, many people remain undiagnosed or misdiagnosed. In addition, in many countries, treatment – if it exists at all – may be at insufficient levels, the research team added. "Although much of the burden [from these illnesses] is either preventable or treatable with affordable interventions, these diseases have received less attention than other prominent non-communicable diseases like ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Dyspnea, Fluticasone, Ribavirin, Qvar, Budesonide, Asthma - Acute, Flovent, Entocort, Bronchial, Tobramycin, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Entocort EC, Mometasone

Climate Change May Trigger 60,000 More Premature Deaths by 2030

Posted 31 Jul 2017 by Drugs.com

MONDAY, July 31, 2017 – If nothing is done to address climate change, tens of thousands more early deaths may occur worldwide from exposure to air pollution in the coming decades, a new study contends. Increases in air pollution caused by rising temperatures will trigger an additional 60,000 premature deaths each year around the globe by 2030, and as many as 260,000 more premature deaths annually by 2100, according to the results of several different climate models. More people will die from diseases like heart attack, stroke, lung cancer and chronic obstructive pulmonary disease (COPD), which are exacerbated by exposure to smog-laden air, said study co-author Jason West. He's an associate professor of environmental sciences and engineering with the University of North Carolina's Gillings School of Global Public Health. The projected deaths occur "under a scenario where no big policies ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Dyspnea, Dehydration, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Heat Stress, Reversible Airways Disease

Health Tip: When Air Quality is Poor

Posted 10 Jul 2017 by Drugs.com

-- Poor air quality is a serious issue for people with breathing problems, such as asthma. When air quality is poor, the National Weather Service suggests: If you're exercising outdoors, make your routine less strenuous than usual Take more frequent breaks. And shorten the length of your workout. Move planned outdoor activities to another day or indoors. If that's not possible, schedule activities in the morning, when air quality generally is better. Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Dyspnea, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Allergic Asthma, Croup, Bronchospastic Disease, Reversible Airways Disease

Opioids a Threat to Seniors With COPD

Posted 6 Jul 2017 by Drugs.com

THURSDAY, July 6, 2017 – Seniors with COPD – a progressive lung disease that causes breathing problems – may increase their odds for heart-related death if they use opioid painkillers, a new study finds. COPD (chronic obstructive pulmonary disorder) patients are often prescribed opioids, including morphine and fentanyl. These narcotics can help treat chronic muscle and bone pain, insomnia, persistent cough and shortness of breath despite inhaler use, the researchers explained. "Previous research has shown about 70 percent of older adults with COPD use opioids, which is an incredibly high rate of new use in a population that is potentially more sensitive to narcotics," said study lead author Dr. Nicholas Vozoris. "Our new findings show there are not only increased risks for coronary artery disease-related death associated with new opioid use, but also increased risk of cardiac-related ... Read more

Related support groups: Suboxone, Oxycodone, Tramadol, Hydrocodone, Methadone, Percocet, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Opana, Subutex, Chronic Obstructive Pulmonary Disease, Heart Attack, Dilaudid, Opana ER, MS Contin

For Many, Friends Are Key to Happiness in Old Age

Posted 29 Jun 2017 by Drugs.com

THURSDAY, July 29, 2017 – As you age, the friends you keep wield an ever-greater impact on your health and sense of happiness, new research reveals. They may even outstrip family in terms of the sway they have over you, according to the pair of new studies. Lead investigator William Chopik cited several reasons why friendships might pack a bigger punch than blood relationships when it comes to influencing health and well-being. "We spend leisure time with friends. We freely choose to continue relationships with friends," said Chopik, an assistant professor of psychology at Michigan State University. If the friendships last until older adulthood, "clearly these are good friendships," he added. "As we age, we prune away at some of the friendships that are more superficial and acquaintance-like," he said. That means that as older adults, "we're left with the ones that are deeper and make ... Read more

Related support groups: Depression, High Blood Pressure, Diabetes, Type 2, Cancer, Major Depressive Disorder, Cough, Osteoarthritis, Hypertension, Ischemic Stroke, High Cholesterol, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Transient Ischemic Attack, Dysthymia, Pre-Diabetes, Chronic Obstructive Pulmonary Disease, Acute, Diabetes Mellitus, Ischemic Stroke - Prophylaxis, Bronchiectasis, Thromboembolic Stroke Prophylaxis

Even at Low Levels, Dirty Air Raises Death Risk for U.S. Seniors

Posted 28 Jun 2017 by Drugs.com

WEDNESDAY, June 28, 2017 – Air pollution may shorten the lives of American seniors, even in areas where levels fall below national safety standards, new research indicates. Although it's possible that factors other than air pollution are responsible for the increase in premature deaths among older adults, study co-author Francesca Dominici said the findings are "bulletproof evidence of increased risk of deaths due to polluted air in the U.S. "Make no mistake. We need to strengthen, not weaken, [U.S. Environmental Protection Agency] air pollution standards," said Dominici, a professor of biostatistics at Harvard T.H. Chan School of Public Health in Boston. "We need to increase, not reduce, the EPA research funding." The investigators launched their research to determine whether pollution levels considered to be acceptable might still be hazardous to human health. "There is extensive ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Dyspnea, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Croup, Bronchospastic Disease, Reversible Airways Disease

Page 1 2 3 4 5 6 Next

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease

Related Drug Support Groups

Symbicort, albuterol, Spiriva, Ventolin, Advair HFA, Advair Diskus, Breo Ellipta, Daliresp, Xopenex, view more... ProAir HFA, Combivent, ipratropium, Atrovent, Anoro Ellipta, Proventil, salmeterol, DuoNeb, Ventolin HFA, tiotropium, glycopyrrolate, Brovana, Stiolto Respimat, Maxair, Proventil HFA, Tudorza Pressair, albuterol / ipratropium, Spiriva Respimat, Atrovent HFA, Serevent Diskus, Alupent, Combivent Respimat, Maxair Autohaler, formoterol, Foradil Aerolizer, Tornalate, ProAir RespiClick, fluticasone / salmeterol, umeclidinium, Utibron Neohaler, Seebri Neohaler, Striverdi Respimat, Incruse Ellipta, levalbuterol, pirbuterol, roflumilast, Bevespi Aerosphere, umeclidinium / vilanterol, Perforomist, Xopenex HFA, Volmax, Airet, formoterol / glycopyrrolate, arformoterol, glycopyrrolate / indacaterol, bitolterol, Vospire ER, olodaterol / tiotropium, budesonide / formoterol, olodaterol, fluticasone / vilanterol, Respirol, Arcapta, metaproterenol, Ipratropium Inhalation Aerosol, Ipratropium Inhalation Solution, aclidinium, AccuNeb, indacaterol, Metaprel, Xopenex Concentrate